Monashee Investment Management LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 65 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Monashee Investment Management LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$912,000
-50.3%
45,000
-82.0%
0.85%
+15.2%
Q1 2017$1,835,000250,0000.74%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
HealthInvest Partners AB 230,000$993,6001.92%
AlphaCentric Advisors LLC 352,500$1,522,8001.50%
NEA Management Company, LLC 3,969,834$17,149,6830.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 573,530$2,477,6500.76%
ARMISTICE CAPITAL, LLC 5,000,000$21,600,0000.38%
IRONWOOD INVESTMENT MANAGEMENT LLC 93,658$404,6030.27%
Artal Group S.A. 1,000,000$4,3200.24%
Virtus ETF Advisers LLC 64,786$279,8760.15%
TANG CAPITAL MANAGEMENT LLC 200,000$864,0000.13%
HighMark Wealth Management LLC 37,499$161,9960.12%
View complete list of AURINIA PHARMACEUTICALS INC shareholders